BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 31547056)

  • 21. Comparative genomic and proteomic analysis of high grade glioma primary cultures and matched tumor in situ.
    Howley R; Kinsella P; Buckley PG; Alcock L; Jansen M; Heffernan J; Stallings RL; Brett FM; Amberger-Murphy V; Farrell MA
    Exp Cell Res; 2012 Oct; 318(17):2245-56. PubMed ID: 22705586
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of platelet-derived growth factor signaling in healing myocardial infarcts.
    Zymek P; Bujak M; Chatila K; Cieslak A; Thakker G; Entman ML; Frangogiannis NG
    J Am Coll Cardiol; 2006 Dec; 48(11):2315-23. PubMed ID: 17161265
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Involvement of CD9 and PDGFR in migration is evolutionarily conserved from Drosophila glia to human glioma.
    Jeibmann A; Halama K; Witte HT; Kim SN; Eikmeier K; Koos B; Klämbt C; Paulus W
    J Neurooncol; 2015 Sep; 124(3):373-83. PubMed ID: 26224160
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of platelet-derived growth factor receptor phosphorylation by STI571 (Gleevec) reduces growth and metastasis of human pancreatic carcinoma in an orthotopic nude mouse model.
    Hwang RF; Yokoi K; Bucana CD; Tsan R; Killion JJ; Evans DB; Fidler IJ
    Clin Cancer Res; 2003 Dec; 9(17):6534-44. PubMed ID: 14695158
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proliferation-independent control of tumor glycolysis by PDGFR-mediated AKT activation.
    Ran C; Liu H; Hitoshi Y; Israel MA
    Cancer Res; 2013 Mar; 73(6):1831-43. PubMed ID: 23322009
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of platelet-derived growth factor receptor tyrosine kinase and downstream signaling pathways by Compound C.
    Kwon HJ; Kim GE; Lee YT; Jeong MS; Kang I; Yang D; Yeo EJ
    Cell Signal; 2013 Apr; 25(4):883-97. PubMed ID: 23277201
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulation of platelet-derived growth factor-induced Ras signaling by poliovirus receptor Necl-5 and negative growth regulator Sprouty2.
    Kajita M; Ikeda W; Tamaru Y; Takai Y
    Genes Cells; 2007 Mar; 12(3):345-57. PubMed ID: 17352739
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Catalytically inactive SHIP2 inhibits proliferation by attenuating PDGF signaling in 3T3-L1 preadipocytes.
    Artemenko Y; Gagnon A; Sorisky A
    J Cell Physiol; 2009 Jan; 218(1):228-36. PubMed ID: 18814181
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization and response of newly developed high-grade glioma cultures to the tyrosine kinase inhibitors, erlotinib, gefitinib and imatinib.
    Kinsella P; Howley R; Doolan P; Clarke C; Madden SF; Clynes M; Farrell M; Amberger-Murphy V
    Exp Cell Res; 2012 Mar; 318(5):641-52. PubMed ID: 22285130
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The involvement of platelet-derived growth factor receptors and insulin-like growth factor-I receptors signaling during mineralized nodule formation by human periodontal ligament cells.
    Nemoto E; Shimonishi M; Nitta Y; Shimauchi H
    J Periodontal Res; 2004 Dec; 39(6):388-97. PubMed ID: 15491343
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epidermal growth factor and platelet-derived growth factor induce expression of Egr-1, a zinc finger transcription factor, in human malignant glioma cells.
    Kaufmann K; Thiel G
    J Neurol Sci; 2001 Aug; 189(1-2):83-91. PubMed ID: 11535237
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Platelet-derived growth factor receptor independent proliferation of human glioblastoma cells: selective tyrosine kinase inhibitors lack antiproliferative activity.
    Gross D; Bernhardt G; Buschauer A
    J Cancer Res Clin Oncol; 2006 Sep; 132(9):589-99. PubMed ID: 16736141
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Present and potential future adjuvant issues in high-grade astrocytic glioma treatment.
    Lefranc F; Rynkowski M; DeWitte O; Kiss R
    Adv Tech Stand Neurosurg; 2009; 34():3-35. PubMed ID: 19368079
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Patient-Specific Screening Using High-Grade Glioma Explants to Determine Potential Radiosensitization by a TGF-β Small Molecule Inhibitor.
    Bayin NS; Ma L; Thomas C; Baitalmal R; Sure A; Fansiwala K; Bustoros M; Golfinos JG; Pacione D; Snuderl M; Zagzag D; Barcellos-Hoff MH; Placantonakis D
    Neoplasia; 2016 Dec; 18(12):795-805. PubMed ID: 27978994
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential roles of ATF-2 in survival and DNA repair contributing to radioresistance induced by autocrine soluble factors in A549 lung cancer cells.
    Desai S; Kumar A; Laskar S; Pandey BN
    Cell Signal; 2014 Nov; 26(11):2424-35. PubMed ID: 25041846
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tyrosine kinase activity of purified recombinant cytoplasmic domain of platelet-derived growth factor beta-receptor (beta-PDGFR) and discovery of a novel inhibitor of receptor tyrosine kinases.
    Zaman GJ; Vink PM; van den Doelen AA; Veeneman GH; Theunissen HJ
    Biochem Pharmacol; 1999 Jan; 57(1):57-64. PubMed ID: 9920285
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recruited cells can become transformed and overtake PDGF-induced murine gliomas in vivo during tumor progression.
    Fomchenko EI; Dougherty JD; Helmy KY; Katz AM; Pietras A; Brennan C; Huse JT; Milosevic A; Holland EC
    PLoS One; 2011; 6(7):e20605. PubMed ID: 21754979
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preclinical therapeutic efficacy of a novel blood-brain barrier-penetrant dual PI3K/mTOR inhibitor with preferential response in PI3K/PTEN mutant glioma.
    Koul D; Wang S; Wu S; Saito N; Zheng S; Gao F; Kaul I; Setoguchi M; Nakayama K; Koyama K; Shiose Y; Sulman EP; Hirota Y; Yung WKA
    Oncotarget; 2017 Mar; 8(13):21741-21753. PubMed ID: 28423515
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Roles of the RAF/MEK/ERK and PI3K/PTEN/AKT pathways in malignant transformation and drug resistance.
    McCubrey JA; Steelman LS; Abrams SL; Lee JT; Chang F; Bertrand FE; Navolanic PM; Terrian DM; Franklin RA; D'Assoro AB; Salisbury JL; Mazzarino MC; Stivala F; Libra M
    Adv Enzyme Regul; 2006; 46():249-79. PubMed ID: 16854453
    [TBL] [Abstract][Full Text] [Related]  

  • 40. GM1 inhibits early signaling events mediated by PDGF receptor in cultured human glioma cells.
    Farooqui T; Kelley T; Coggeshall KM; Rampersaud AA; Yates AJ
    Anticancer Res; 1999; 19(6B):5007-13. PubMed ID: 10697503
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.